Affordable Access

Publisher Website

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen.

Authors
Journal
Journal of Clinical Oncology
0732-183X
Publisher
American Society of Clinical Oncology
Publication Date
Volume
28
Issue
3
Identifiers
DOI: 10.1200/jco.2009.23.1274
Keywords
  • Aged
  • Antineoplastic Agents
  • Aromatase Inhibitors
  • Breast Neoplasms
  • Chemotherapy
  • Adjuvant
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Randomized Controlled Trials As Topic
  • Tamoxifen
Disciplines
  • Medicine

Abstract

To conduct meta-analyses of randomized trials of aromatase inhibitors (AIs) compared with tamoxifen either as initial monotherapy (cohort 1) or after 2 to 3 years of tamoxifen (cohort 2).

There are no comments yet on this publication. Be the first to share your thoughts.